{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:47:59Z","timestamp":1792514879185,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jdiacomp.2025.109108","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T06:10:46Z","timestamp":1749449446000},"page":"109108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Technosphere insulin in the treatment of Type 1 diabetes mellitus: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"39","author":[{"given":"Vit\u00f3ria Karoline Justino Dos","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Lucas De Lima","family":"Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Sim\u00f5es Noel","family":"Da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iapunira Catarina","family":"Sant'anna Arag\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Matheus","family":"Sant'anna Arag\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor Henrique Justino Dos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa Calixto","family":"Hespanhol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Lins","family":"De Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Prado","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Aderval","family":"Arag\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2025.109108_bb0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41574-020-00443-4","article-title":"Type 1 diabetes mellitus as a disease of the \u03b2-cell (do not blame the immune system?)","volume":"17","author":"Roep","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/jama.2014.16107","article-title":"Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality","volume":"313","author":"Orchard","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/dc13-2112","article-title":"The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: overview","volume":"37","author":"Nathan","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0020","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/00325481.2016.1229555","article-title":"A novel option for prandial insulin therapy: inhaled insulin","volume":"128","author":"Dailey","year":"2016","journal-title":"Postgrad Med"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0025","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(97)06234-X","article-title":"Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus","volume":"350","author":"Morris","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0030","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1345\/aph.1P055","article-title":"A review of inhaled Technosphere insulin","volume":"44","author":"Neumiller","year":"2010","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0035","doi-asserted-by":"crossref","DOI":"10.1089\/dia.2007.0212","article-title":"Technosphere \u00ae insulin technology","volume":"9","author":"Richardson","year":"2007","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0040","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"n71","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0045","series-title":"Cochrane handbook for systematic reviews of interventions version 6.5 (updated August 2024)","year":"2024"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0050","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.2337\/dc15-0075","article-title":"Inhaled technosphere insulin compared with injected prandial insulin in type 1 diabetes: a randomized 24-week trial","volume":"38","author":"Bode","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0055","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1089\/dia.2018.0200","article-title":"Improved postprandial glucose with inhaled technosphere insulin compared with insulin aspart in patients with type 1 diabetes on multiple daily injections: The STAT study","volume":"20","author":"Akturk","year":"2018","journal-title":"Diabetes Technology and Therapeutics"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0060","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.2337\/dc20-0091","article-title":"Effect of afrezza on glucose dynamics during HCL treatment","volume":"43","author":"Galderisi","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0065","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/1753-0407.13099","article-title":"Understanding inhaled Technosphere insulin: results of an early randomized trial in type 1 diabetes mellitus","volume":"13","author":"McGill","year":"2021","journal-title":"J Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0070","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S2213-8587(15)00280-6","article-title":"Efficacy, safety, and patient acceptability of Technosphere inhaled insulin for people with diabetes: a systematic review and meta-analysis","volume":"3","author":"Pittas","year":"2015","journal-title":"The Lancet Diabetes & Endocrinology"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0075","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncpendmet1007","article-title":"Inhaled insulin\u2014what went wrong","volume":"5","author":"Mitri","year":"2009","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0080","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.2337\/dc24-S006","article-title":"6. Glycemic goals and hypoglycemia: standards of Care in Diabetes\u20142024","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0085","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/1932296816658055","article-title":"Pharmacokinetic and Pharmacodynamic properties of a novel inhaled insulin","volume":"11","author":"Heinemann","year":"2017","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0090","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ecl.2010.05.011","article-title":"Epidemiology of type 1 diabetes","volume":"39","author":"Maahs","year":"2010","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0095","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4158\/EP09294.RA","article-title":"Rapid-acting insulin analogues in basal-bolus regimens in type 1 diabetes mellitus","volume":"16","author":"Garg","year":"2010","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0100","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/0145721708317869","article-title":"Measuring psychological insulin resistance","volume":"34","author":"Larkin","year":"2008","journal-title":"Diabetes Educ"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0105","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1089\/dia.2024.0582","article-title":"Inhaled Technosphere insulin plus insulin Degludec for adults with type 1 diabetes: The INHALE-3 extension study","volume":"27","author":"Beck","year":"2025","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0110","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1464-5491.2012.03646.x","article-title":"Contemporary rates of severe hypoglycaemia in youth with type 1 diabetes: variability by insulin regimen","volume":"29","author":"Katz","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1017\/S0033291709005777","article-title":"Cognitive functions and glycemic control in children and adolescents with type 1 diabetes","volume":"40","author":"Ohmann","year":"2010","journal-title":"Psychol Med"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","article-title":"Health effects of overweight and obesity in 195 countries over 25 years","volume":"377","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0125","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.2169\/internalmedicine.51.7410","article-title":"High body mass index is an important risk factor for the development of type 2 diabetes","volume":"51","author":"Sanada","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00508-018-1434-9","article-title":"Overweight and obesity in type 1 diabetes equal those of the general population","volume":"131","author":"Fellinger","year":"2019","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0135","doi-asserted-by":"crossref","first-page":"151","DOI":"10.7570\/jomes22061","article-title":"Association between body mass index and mortality in type 1 diabetes mellitus: a systematic review and Meta-analysis","volume":"32","author":"Jung","year":"2023","journal-title":"Journal of Obesity & Metabolic Syndrome"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0140","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/dc16-2215","article-title":"Glucose concentrations of less than 3.0 mmol\/L (54 mg\/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"40","author":"International Hypoglycaemia Study Group","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0145","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJMoa066397","article-title":"Long-term effect of diabetes and its treatment on cognitive function","volume":"356","author":"Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Study Research Group","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0150","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00405006","article-title":"Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus","volume":"34","author":"Langan","year":"1991","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0155","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/BF00404042","article-title":"Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in man","volume":"33","author":"Wredling","year":"1990","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2025.109108_bb0160","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","author":"Sterne","year":"2019","journal-title":"BMJ"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872725001618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872725001618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T14:47:01Z","timestamp":1751899621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872725001618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1056872725001618"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109108","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Technosphere insulin in the treatment of Type 1 diabetes mellitus: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109108"}}